Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $238.31, moving -1.59% from the previous trading session.

VRTX : 238.31 (-1.59%)
Top Research Reports for Amazon, Medtronic & Vertex

Top Research Reports for Amazon, Medtronic & Vertex

VRTX : 238.31 (-1.59%)
MDT : 86.27 (+0.14%)
INTU : 218.39 (-3.03%)
FE : 37.95 (-5.12%)
BAYRY : 14.3400 (-0.62%)
AMZN : 1,906.59 (-0.64%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Vertex Pharm (VRTX , GILD , AMGN , INCY , ABBV )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AMGN : 205.41 (-1.66%)
GILD : 78.21 (+1.60%)
VRTX : 238.31 (-1.59%)
3 Drugmakers Still Worth Betting on Amid Coronavirus Woes

Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.

PFE : 33.64 (+2.34%)
AMAG : 6.14 (+0.99%)
LLY : 139.66 (-1.77%)
VRTX : 238.31 (-1.59%)
CPIX : 3.70 (+2.49%)
MIST : 1.7700 (-0.56%)
Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year?

Is (VRTX) Outperforming Other Medical Stocks This Year?

VRTX : 238.31 (-1.59%)
Vertex to Halt Enrollment Due to Coronavirus, Keeps Sales View

Vertex (VRTX) announces plan to halt enrollment and delay study initiation amid coronavirus pandemic. However, it does not expect any supply chain disruption and maintains its business outlook for 2020....

PFE : 33.64 (+2.34%)
LLY : 139.66 (-1.77%)
BMY : 55.53 (+0.58%)
VRTX : 238.31 (-1.59%)
SmarTrend Watching for Potential Pullback in Shares of Vertex Pharm After 5.99% Gain

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $220.00 to a high of $233.77. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of...

VRTX : 238.31 (-1.59%)
Watch for Vertex Pharm to Potentially Pullback After Gaining 5.99% Yesterday

Vertex Pharm (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $220.00 to a high of $233.77. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of...

VRTX : 238.31 (-1.59%)
Vertex Confirms Supply Chain Continuity and Business Outlook for Its Cystic Fibrosis Medicines and Provides Initial Update on Development Programs

Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today confirmed its 2020 business outlook and the continuity of the company's supply chain for its approved cystic fibrosis (CF) medicines and provided...

VRTX : 238.31 (-1.59%)
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $213.52, moving +1.46% from the previous trading session.

VRTX : 238.31 (-1.59%)
Sickle Cell Anemia Industry Outlook to 2026 Featuring CRISPR Therapeutics, Global Blood Therapeutics, Novartis, Pfizer, and Vertex Pharmaceuticals

The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering.

CRSP : 39.38 (-0.33%)
GBT : 52.66 (+4.15%)
NVS : 83.64 (+0.05%)
VRTX : 238.31 (-1.59%)
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals

Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals

VRTX : 238.31 (-1.59%)
FN : 52.65 (-2.32%)
DQ : 51.42 (-4.94%)
LITE : 66.86 (-4.70%)
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals

REGN : 493.32 (-1.09%)
MRNA : 34.84 (+4.94%)
VRTX : 238.31 (-1.59%)
CODX : 8.20 (-3.64%)
4 Top Biotech Stocks to Buy in the Time of Coronavirus

We have picked biotech companies that are widely expected to develop a vaccine for the coronavirus and fight off the worst stock market carnage since the 2008 financial crisis.

REGN : 493.32 (-1.09%)
MRNA : 34.84 (+4.94%)
VRTX : 238.31 (-1.59%)
CODX : 8.20 (-3.64%)
Pick These 4 Stocks With Impressive Interest Coverage Ratio

Debt, which is crucial to financing operations for the majority of companies, comes at a cost called interest. Interest expense has a direct bearing on the profitability of a company.

VRTX : 238.31 (-1.59%)
FN : 52.65 (-2.32%)
DQ : 51.42 (-4.94%)
LITE : 66.86 (-4.70%)
Geron's (GERN) Q4 Earnings and Revenues Surpass Estimates

Geron (GERN) reports encouraging fourth-quarter 2019 results. Operating expenses increase on a year-over-year basis.

JNJ : 134.17 (+0.77%)
REGN : 493.32 (-1.09%)
GERN : 1.0500 (unch)
VRTX : 238.31 (-1.59%)
BioDelivery (BDSI) Q4 Earnings and Revenues Beat Estimates

BioDelivery (BDSI) beats earnings and sales expectations for the fourth quarter of 2019.

ENDP : 3.18 (+2.91%)
REGN : 493.32 (-1.09%)
VRTX : 238.31 (-1.59%)
BDSI : 3.79 (+0.26%)
The Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak Response

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Vertex Foundation, a nonprofit charitable foundation, is making a $500,000 gift to Partners HealthCare, a Boston-based nonprofit...

VRTX : 238.31 (-1.59%)
Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?

Is (VRTX) Outperforming Other Medical Stocks This Year?

VRTX : 238.31 (-1.59%)
Thinking about trading options or stock in Johnson & Johnson, Netflix, Vertex Pharmaceuticals, Slack Technologies, or Zoom Video Communications?

InvestorsObserver issues critical PriceWatch Alerts for JNJ, NFLX, VRTX, WORK, and ZM.

JNJ : 134.17 (+0.77%)
NFLX : 361.76 (-2.25%)
VRTX : 238.31 (-1.59%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -2.23 , SEDG -2.49 , THC -1.30 , TER -0.57 , LITE -3.30
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar